BioCardia Inc.
Organization details
- Legal name
- BioCardia Inc.
- Former names
- Tiger X Medical, Inc. Cardo Medical, Inc. Clicknsettle COM Inc NAM Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Sunnyvale
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BCDA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000925741
- EIN
- 23-2753988
Board of directors
-
Andrew Scott Blank · DirectorSince 2023
-
Bill Facteau · DirectorSince 2023
-
Jay M. Moyes · DirectorSince 2023
-
Jim L. Allen · DirectorSince 2023
-
Krisztina M. Zsebo · DirectorSince 2023
-
Marvin Slosman · DirectorSince 2025
-
Peter Altman · Director · President and CEOSince 2023
-
Richard M. Krasno · DirectorSince 2023
-
Simon H. Stertzer · DirectorSince 2023
Chief executives
Director election results
Annual meeting of December 2, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.7%
-
94.7%
-
94.9%
Board connections
3 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
InspireMD Inc. Same sectorvia Marvin Slosman
-
OPKO Health Inc. Same sectorvia Richard M. Krasno
-
Puma Biotechnology Inc Same sectorvia Jay M. Moyes
-
SiNtx Technologies Inc. Same sectorvia Jay M. Moyes
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $169,641
- 34 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 16, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +300 | $0.95 | $285 |
| Oct 15, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +200 | $0.95 | $190 |
| Sep 29, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,000 | $1.03 | $1,030 |
| Sep 23, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,900 | $1.05 | $1,995 |
| Sep 3, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +800 | $1.09 | $872 |
| Aug 17, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,400 | $0.93 | $5,022 |
| Aug 13, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,900 | $0.92 | $1,748 |
| Jul 29, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,000 | $0.78 | $3,900 |
| Jul 17, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +500 | $0.83 | $415 |
| Jul 15, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,500 | $0.86 | $1,290 |
| Jul 14, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +2,800 | $0.88 | $2,464 |
| Jul 10, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,000 | $0.94 | $940 |
| Jul 9, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,000 | $0.90 | $900 |
| Jul 8, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,400 | $0.96 | $5,184 |
| Jul 8, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,500 | $0.97 | $5,335 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about BioCardia Inc.
Who is the CEO of BioCardia Inc.?
Peter Altman is BioCardia Inc.'s President and CEO.
How many directors are on BioCardia Inc.'s board?
BioCardia Inc.'s board has 9 directors: Andrew Scott Blank, Bill Facteau, Jay M. Moyes, Jim L. Allen, Krisztina M. Zsebo, Marvin Slosman, Peter Altman, Richard M. Krasno and Simon H. Stertzer.
Are BioCardia Inc. insiders buying or selling shares?
Over the last 12 months, BioCardia Inc. insiders bought $169,641 of shares in 34 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="biocardia-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.